• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Ionis Pharmaceuticals, Inc. - Common Stock (NQ:IONS)

    70.73 +0.77 (+1.10%)
    Streaming Delayed Price Updated: 1:04 PM EDT, Oct 9, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 838,467
    Open 70.21
    Bid (Size) 70.71 (3)
    Ask (Size) 70.75 (4)
    Prev. Close 69.96
    Today's Range 69.68 - 70.89
    52wk Range 23.95 - 71.87
    Shares Outstanding 141,797,854
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Ionis Pharmaceuticals (NASDAQ:IONS) Ascends to Six-Year High, Fueled by Breakthrough Pipeline and Robust Sales Outlook
    Carlsbad, CA – October 8, 2025 – Ionis Pharmaceuticals (NASDAQ:IONS) is currently witnessing a remarkable surge in its stock value, nearing a six-year high. This impressive ascent is largely driven by... 
    Via MarketMinute
    Why Ionis Stock, Approaching A Six-Year High, Just Snagged A Price-Target Hike
    The company is working toward a potential $5 billion sales peak for its partnered and unpartnered programs. 
    Via Investor's Business Daily

    Performance

    YTD
    +103.9%
    +103.9%
    1 Month
    +16.0%
    +16.0%
    3 Month
    +65.1%
    +65.1%
    6 Month
    +154.7%
    +154.7%
    1 Year
    +87.1%
    +87.1%

    More News

    Read More
    This Penumbra Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
    Via Benzinga
    Ionis Pharma Stock Rises After Multiple Price Target Hikes On Heels Of Positive Study Results In Alexander Disease
    Via Stocktwits
    Ionis showcases transformational medicines and industry-leading pipeline at Innovation Day
    From Ionis Pharmaceuticals, Inc.
    Via Business Wire
    Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen
    From Biogen Inc.
    Via GlobeNewswire
    What Analysts Are Saying About Ionis Pharmaceuticals Stock
    Via Benzinga
    Ionis Pharmaceuticals Reveals 'Unprecedented Results' From Rare Neurological Disease Trial
    Via Benzinga
    Ionis announces positive topline results from pivotal study of zilganersen in Alexander disease
    From Ionis Pharmaceuticals, Inc.
    Via Business Wire
    TRYNGOLZA® (olezarsen) approved in the European Union for familial chylomicronemia syndrome (FCS)
    From Ionis Pharmaceuticals, Inc.
    Via Business Wire
    Biogen to Acquire Alcyone Therapeutics, Expanding Drug Delivery Solution Portfolio for Key Product and Pipeline Candidates
    From Biogen Inc.
    Via GlobeNewswire
    Ionis expands Surf Away+ event, marking 10 years of creating unique adaptive experiences for people with neurological diseases
    From Ionis Pharmaceuticals, Inc.
    Via Business Wire
    Ionis Pharmaceuticals To Expedite Development Of Rare Neurological Disease Candidate With FDA Breakthrough Status
    Via Benzinga
    Ionis receives U.S. FDA Breakthrough Therapy designation for ION582 in Angelman syndrome
    From Ionis Pharmaceuticals, Inc.
    Via Business Wire
    Ionis to host investors and analysts for Innovation Day 2025
    From Ionis Pharmaceuticals, Inc.
    Via Business Wire
    Ionis to present at upcoming investor conferences
    From Ionis Pharmaceuticals, Inc.
    Via Business Wire
    Here are the top movers in Tuesday's session.
    Via Chartmill
    IONS Stock Soars 34% To Hit February 2021 Highs After Medicine Shows Positive Effect On Elevated Triglyceride Levels In Late-Stage Studies
    Via Stocktwits
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Ionis Pharma's Investigational Drug Shows Promise For Triglyceride And Pancreatitis Reduction
    Via Benzinga
    There are notable gap-ups and gap-downs in today's session.
    Via Chartmill
    Ionis Pharma Hits The 'Bull Case,' 'Blue Sky' In Lowering Triglycerides. Shares Launch.
    Via Investor's Business Daily
    Olezarsen significantly reduces triglycerides and acute pancreatitis events in landmark pivotal studies for people with severe hypertriglyceridemia (sHTG)
    From Ionis Pharmaceuticals, Inc.
    Via Business Wire
    IONIS PHARMACEUTICALS INC (NASDAQ:IONS) Presents a High-Probability Technical Breakout Setup
    Via Chartmill

    Frequently Asked Questions

    Is Ionis Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Ionis Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Ionis Pharmaceuticals, Inc. - Common Stock trade on?
    Ionis Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Ionis Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Ionis Pharmaceuticals, Inc. - Common Stock is IONS on the Nasdaq Stock Market
    What is the current price of Ionis Pharmaceuticals, Inc. - Common Stock?
    The current price of Ionis Pharmaceuticals, Inc. - Common Stock is 70.73
    When was Ionis Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Ionis Pharmaceuticals, Inc. - Common Stock was at 10/09/25 01:04 PM ET
    What is the market capitalization of Ionis Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Ionis Pharmaceuticals, Inc. - Common Stock is 10.03B
    How many shares of Ionis Pharmaceuticals, Inc. - Common Stock are outstanding?
    Ionis Pharmaceuticals, Inc. - Common Stock has 10B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.